MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-10-2026
Pulmonx Corporation Operating Expenses 2011-2026 | LUNG
Annual Operating Expenses Pulmonx Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121 M | 120 M | 113 M | 98.5 M | 82.9 M | 53.5 M | 40.3 M | 27.3 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 121 M | 27.3 M | 82 M |
Quarterly Operating Expenses Pulmonx Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 30.4 M | 32 M | 30.9 M | - | 29.2 M | 30.9 M | 28.6 M | - | 28.2 M | 29.2 M | 27 M | - | 24.1 M | 24.8 M | 23.8 M | - | 19.5 M | 21.7 M | 19.1 M | - | 12.8 M | 12.5 M | 11.8 M | - | 10 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 32 M | 10 M | 23.5 M |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Electromed
ELMD
|
40.3 M | $ 25.6 | -1.63 % | $ 216 M |  USA |
 |
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | USA |
 |
Helius Medical Technologies
HSDT
|
12.5 M | $ 1.98 | -4.81 % | $ 1.2 M | USA |
 |
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | USA |
 |
AdaptHealth Corp.
AHCO
|
59.6 M | $ 13.09 | -2.17 % | $ 1.77 B | USA |
 |
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | USA |
 |
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | USA |
 |
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | USA |
 |
BioSig Technologies
BSGM
|
71.1 M | - | 37.08 % | $ 85.7 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | USA |
 |
Orthofix Medical
OFIX
|
344 M | $ 11.64 | -2.27 % | $ 461 M |  Curacao |
 |
EDAP TMS S.A.
EDAP
|
20.8 M | $ 3.43 | 3.78 % | $ 128 M |  France |
 |
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | USA |
 |
Insulet Corporation
PODD
|
531 M | $ 178.47 | -2.41 % | $ 12.6 B | USA |
 |
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
41.2 M | $ 0.62 | 3.3 % | $ 38.6 M | USA |
 |
ClearPoint Neuro
CLPT
|
15.3 M | $ 10.53 | -4.96 % | $ 298 M | USA |
 |
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | USA |
 |
Sintx Technologies
SINT
|
11.2 M | $ 2.1 | -2.33 % | $ 5.82 M | USA |
 |
Globus Medical
GMED
|
547 M | $ 89.22 | -1.68 % | $ 12.1 B | USA |
 |
Eargo
EAR
|
126 M | - | - | $ 10.2 M | USA |
 |
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | USA |
 |
Second Sight Medical Products
EYES
|
27.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Tactile Systems Technology
TCMD
|
221 M | $ 22.9 | -2.84 % | $ 524 M | USA |
 |
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | USA |
 |
TELA Bio
TELA
|
88.1 M | $ 0.75 | -3.78 % | $ 35.2 M | USA |
 |
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | USA |
 |
TransMedics Group
TMDX
|
254 M | $ 100.07 | -1.18 % | $ 3.4 B | USA |
 |
Tandem Diabetes Care
TNDM
|
159 M | $ 17.71 | -4.94 % | $ 1.2 B | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M |  Canada |
 |
Butterfly Network
BFLY
|
123 M | $ 4.88 | -5.43 % | $ 1.03 B | USA |
 |
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | USA |
 |
Varex Imaging Corporation
VREX
|
318 M | $ 11.44 | -5.26 % | $ 474 M | USA |
 |
Vivos Therapeutics
VVOS
|
30.4 M | $ 0.82 | -3.92 % | $ 8.42 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
212 M | $ 14.82 | -2.11 % | $ 348 M | USA |
 |
Delcath Systems
DCTH
|
72.8 M | $ 10.35 | -1.94 % | $ 371 M | USA |
 |
IRIDEX Corporation
IRIX
|
21.8 M | $ 1.04 | - | $ 17.6 M | USA |
 |
CONMED Corporation
CNMD
|
648 M | $ 36.47 | -0.87 % | $ 1.13 B | USA |
 |
LivaNova PLC
LIVN
|
697 M | $ 59.46 | -2.99 % | $ 3.24 B |  Britain |
 |
Inspire Medical Systems
INSP
|
240 M | $ 53.67 | -2.61 % | $ 1.58 B | USA |
 |
LENSAR
LNSR
|
32.6 M | $ 5.25 | -1.87 % | $ 62.8 M | USA |
 |
Integer Holdings Corporation
ITGR
|
279 M | $ 84.27 | -0.44 % | $ 2.93 B | USA |